Confronto
Pramlintid vs. Survodutide
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Metabolico
Metabolico
N. CAS
151126-32-8
2179963-22-7
Peso molecolare
3949.4 g/mol
4727 g/mol
Emivita
nessun dato
168 h
Sequenza
nessun dato
modifiziertes 29-Aminosäuren-Peptid mit FettsäureseitenketteMeccanismo d'azione
Pramlintid
Pramlintide mimics the beta-cell hormone amylin, which is co-secreted with insulin. It slows gastric emptying, suppresses postprandial glucagon release and promotes satiety — thereby blunting post-meal blood-glucose spikes.
Survodutide
Survodutide is a dual agonist at the GLP-1 and glucagon receptors. The GLP-1 component mediates glucose-dependent insulin secretion, inhibition of glucagon secretion at high blood glucose and modulation of satiety. The glucagon component raises basal energy expenditure via hepatic and brown adipocyte effects. A fatty-acid side chain enables albumin binding and weekly dosing.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
0
4
di cui sull'uomo
0
4
Effetti registrati
2
3
Contraddizioni aperte
1
1
Eventi avversi documentati
2
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Pramlintid and Survodutide?
- Pramlintid is classified as "Metabolico", while Survodutide is classified as "Metabolico". Pramlintid: Pramlintide is a synthetic analog of the hormone amylin. It is used as an adjunct to mealtime insulin therapy in type 1 and type 2 diabetes and, among other things, slows gastric emptying. Survodutide: Synthetic peptide that simultaneously activates the GLP-1 and glucagon receptors. Developed by Boehringer Ingelheim and Zealand Pharma; in phase-3 trials for obesity (SYNCHRONIZE) and MASH. No marketing approval yet. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Pramlintid or Survodutide?
- The highest available evidence level is "RCT sull'uomo" for Pramlintid and "RCT sull'uomo" for Survodutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Pramlintid and Survodutide in Germany and the United States?
- Germania: Pramlintid — Non approvato, Survodutide — Non approvato. Stati Uniti: Pramlintid — Su prescrizione, Survodutide — Non approvato. These are factual summaries with source and review date on the individual pages.